Aviance Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Aviance Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$3K	Sell	55 -70,398	-100%	-$3.51M	﹤0.01%	207
2018 Q4	$3.66M	Buy	+70,453	New	+$3.79M	0.51%	55
2018 Q2	–	Sell	-33	Closed	-$2K	–	211
2018 Q1	$2K	Sell	33 -12,132	-100%	-$780K	﹤0.01%	257
2017 Q4	$745K	Sell	12,165 -685	-5%	-$42.8K	0.05%	135
2017 Q3	$819K	Sell	12,850 -28,252	-69%	-$1.65M	0.06%	127
2017 Q2	$2.29M	Buy	41,102 +12,896	+46%	+$702K	0.14%	92
2017 Q1	$1.53M	Buy	+28,206	New	+$1.55M	0.09%	111
2016 Q3	–	Sell	-13,434	Closed	-$988K	–	329
2016 Q2	$988K	Buy	+13,434	New	+$949K	0.03%	205
2014 Q4	–	Sell	-28,206	Closed	-$1.44M	–	310
2014 Q3	$1.44M	Buy	28,206 +8,866	+46%	+$443K	0.06%	160
2014 Q2	$938K	Buy	19,340 +5,163	+36%	+$254K	0.04%	173
2014 Q1	$736K	Buy	14,177 +11,409	+412%	+$607K	0.04%	170
2013 Q4	$147K	Buy	2,768 +74	+3%	+$3.77K	0.08%	157
2013 Q3	$125K	Sell	2,694 -11,262	-81%	-$494K	0.07%	163
2013 Q2	$624K	Buy	+13,956	New	+$606K	0.34%	74

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Aviance Capital Management's BMY Position: Q1 2019 in Review

Aviance Capital Management reduced its Bristol-Myers Squibb (BMY) stake by 100% in Q1 2019, selling an estimated $3.51M and leaving 55 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #207.

Aviance Capital Management first reported a position in BMY in Q2 2013 and has held it in 14 quarters since. The position peaked at $3.66M in Q4 2018. 1,814 funds tracked by Wall St. Rank hold BMY as of Q1 2019.

Aviance Capital Management held 55 shares of Bristol-Myers Squibb worth $3K as of Q1 2019.
Aviance Capital Management sold 70,398 Bristol-Myers Squibb shares in Q1 2019, an estimated $3.51M.
Bristol-Myers Squibb made up ﹤0.01% of Aviance Capital Management's portfolio in Q1 2019, its #207 holding.
Aviance Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 14 quarters since.
Aviance Capital Management's Bristol-Myers Squibb position peaked at $3.66M in Q4 2018.
1,814 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2019.

Based on Aviance Capital Management's 13F filing for Q1 2019, filed 15 May 2019.